Fault Diagnosis of Supervision and Homogenization Distance Based on Local Linear Embedding Algorithm

In view of the problems of uneven distribution of reality fault samples and dimension reduction effect of locally linear embedding (LLE) algorithm which is easily affected by neighboring points, an improved local linear embedding algorithm of homogenization distance (HLLE) is developed. The method makes the overall distribution of sample points tend to be homogenization and reduces the influence of neighboring points using homogenization distance instead of the traditional Euclidean distance. It is helpful to choose effective neighboring points to construct weight matrix for dimension reduction. Because the fault recognition performance improvement of HLLE is limited and unstable, the paper further proposes a new local linear embedding algorithm of supervision and homogenization distance (SHLLE) by adding the supervised learning mechanism. On the basis of homogenization distance, supervised learning increases the category information of sample points so that the same category of sample points will be gathered and the heterogeneous category of sample points will be scattered. It effectively improves the performance of fault diagnosis and maintains stability at the same time. A comparison of the methods mentioned above was made by simulation experiment with rotor system fault diagnosis, and the results show that SHLLE algorithm has superior fault recognition performance

Enhanced cycling stability of Li–O2 batteries by using a polyurethane/SiO2/glass fiber nanocomposite separator

A considerable improvement in the cycle performance of aprotic Li–O2 batteries was achieved by using a polyurethane/SiO2 gel nanoparticles/glass fiber (PU/SiO2/GF) nanocomposite separator, where a persistent capability of 1000 mA h g−1 was maintained for at least 300 charge/discharge cycles in a DMSO electrolyte with 1 M LiClO4 and 0.05 M LiI. In comparison, the cell with a conventional GF separator in the same experimental setup only run for 60 cycles. SEM, XRD and FT-IR analyses indicate that the corrosion and dendritic growth of the Li anode were significantly inhibited during the charge/discharge cycling, and the eventual failure of the Li–O2 batteries was attributed to the cathode passivation caused by the accumulation of the discharge product, which blocked the transfer of oxygen and electrolyte to the MWNTs cathode

Combining PD-1 or PD-L1 inhibitors with chemotherapy is a good strategy for the treatment of extensive small cell lung cancer: A retrospective analysis of clinical studies

ObjectivesTo provide an updated systematic review and meta-analysis of published randomized controlled trials (RCTs) of the efficacy and safety of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors combined with chemotherapy versus chemotherapy alone in the treatment of extensive-stage small-cell lung cancer (ES-SCLC).MethodsPubMed, Web of Science, Embase, Clinicaltrials and the Cochrane Library were systematically searched to extract RCTs concerning the efficacy and safety of PD-1/PD-L1 inhibitors combined with chemotherapy versus chemotherapy alone in the treatment of ES-SCLC from the time of database inception to October 31, 2022. The literature was independently selected, information was extracted and the risk of bias of the RCTs was evaluated according to the inclusion and exclusion criteria. Stata14.0 was used for the meta-analysis.ResultsSix studies involving 2,600 patients were included in the analysis. The results of the meta-analysis showed that the combination of PD-1/PD-L1 inhibitors significantly improved the OS (HR: 0.73, 95% CI: 0.66-0.80; P<0.0001), prolonged PFS (HR: 0.66,95% CI: 0.55-0.79; P<0.0001) and did not increase overall incidence of treatment-related adverse events (TRAEs) (RR: 1.03, 95% CI: 0.97-1.09; P=0.330) in ES-SCLC patients compared with chemotherapy alone. The subgroup analysis found that patients with negative PD-L1 expression (< 1%) benefited in OS, whereas patients with positive PD-L1 expression (≥1%) had no statistically significant difference in OS. There was a statistically significant difference in PFS between PD-L1-negative (< 1%) and PD-L1-positive (≥1%) patients. The addition of a PD-1 inhibitor or PD-L1 inhibitor to the chemotherapy regimen can improve OS and prolong PFS in patients with ES-SCLC.ConclusionsPD-1/PD-L1 inhibitors combination chemotherapy significantly improves PFS and OS in ES-SCLC patients without increasing the overall incidence of TRAEs

Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer.

Gastric cancer (GC) is a major cause of global cancer mortality. Genetic variations in DNA repair genes can modulate DNA repair capability and, consequently, have been associated with risk of developing cancer. We have previously identified a T to C point mutation at nucleotide 889 (T889C) in DNA polymerase beta (POLB) gene, a key enzyme involved in base excision repair in primary GCs. The purpose of this study was to evaluate the mutation and expression of POLB in a larger cohort and to identify possible prognostic roles of the POLB alterations in GC. Primary GC specimens and their matched normal adjacent tissues were collected at the time of surgery. DNA, RNA and protein samples were isolated from GC specimens and cell lines. Mutations were detected by PCR-RFLP/DHPLC and sequencing analysis. POLB gene expression was examined by RT-PCR, tissue microarray, Western blotting and immunofluorescence assays. The function of the mutation was evaluated by chemosensitivity, MTT, Transwell matrigel invasion and host cell reactivation assays. The T889C mutation was detected in 18 (10.17%) of 177 GC patients. And the T889C mutation was associated with POLB overexpression, lymph nodes metastases and poor tumor differentiation. In addition, patients with- the mutation had significantly shorter survival time than those without-, following postoperative chemotherapy. Furthermore, cell lines with T889C mutation in POLB gene were more resistant to the treatment of 5-fluorouracil, cisplatin and epirubicin than those with wild type POLB. Forced expression of POLB gene with T889C mutation resulted in enhanced cell proliferation, invasion and resistance to anticancer drugs, along with increased DNA repair capability. These results suggest that POLB gene with T889C mutation in surgically resected primary gastric tissues may be clinically useful for predicting responsiveness to chemotherapy in patients with GC. The POLB gene alteration may serve as a prognostic biomarker for GC

Clinical Significance of a Point Mutation in DNA Polymerase Beta (POLB) Gene in Gastric Cancer.

Gastric cancer (GC) is a major cause of global cancer mortality. Genetic variations in DNA repair genes can modulate DNA repair capability and, consequently, have been associated with risk of developing cancer. We have previously identified a T to C point mutation at nucleotide 889 (T889C) in DNA polymerase beta (POLB) gene, a key enzyme involved in base excision repair in primary GCs. The purpose of this study was to evaluate the mutation and expression of POLB in a larger cohort and to identify possible prognostic roles of the POLB alterations in GC. Primary GC specimens and their matched normal adjacent tissues were collected at the time of surgery. DNA, RNA and protein samples were isolated from GC specimens and cell lines. Mutations were detected by PCR-RFLP/DHPLC and sequencing analysis. POLB gene expression was examined by RT-PCR, tissue microarray, Western blotting and immunofluorescence assays. The function of the mutation was evaluated by chemosensitivity, MTT, Transwell matrigel invasion and host cell reactivation assays. The T889C mutation was detected in 18 (10.17%) of 177 GC patients. And the T889C mutation was associated with POLB overexpression, lymph nodes metastases and poor tumor differentiation. In addition, patients with- the mutation had significantly shorter survival time than those without-, following postoperative chemotherapy. Furthermore, cell lines with T889C mutation in POLB gene were more resistant to the treatment of 5-fluorouracil, cisplatin and epirubicin than those with wild type POLB. Forced expression of POLB gene with T889C mutation resulted in enhanced cell proliferation, invasion and resistance to anticancer drugs, along with increased DNA repair capability. These results suggest that POLBgene with T889C mutation in surgically resected primary gastric tissues may be clinically useful for predicting responsiveness to chemotherapy in patients with GC. The POLB gene alteration may serve as a prognostic biomarker for GC

A facile surface preservation strategy on the lithium anode for high performance Li-O2 batteries

Protecting an anode from deterioration during charging/discharging has been seen as one of the key strategies in achieving high-performance lithium (Li)–O2 batteries and other Li–metal batteries with a high energy density. Here, we describe a facile approach to prevent the Li anode from dendritic growth and chemical corrosion by constructing a SiO2/GO hybrid thin layer on the surface. The uniform pore-preserving layer can conduct Li ions in the stripping/plating process, leading to an effective alleviation of the dendritic growth of Li by guiding the ion flux through the microstructure. Such a preservation technique significantly enhances the cell performance by enabling the Li–O2 cell to cycle up to 348 times at 1 A·g–1 with a capacity of 1000 mA·h·g–1, which is several times the cycles of cells with pristine Li (58 cycles), Li–GO (166 cycles), and Li–SiO2 (187 cycles). Moreover, the rate performance is improved, and the ultimate capacity of the cell is dramatically increased from 5400 to 25,200 mA·h·g–1. This facile technology is robust and conforms to the Li surface, which demonstrates its potential applications in developing future high-performance and long lifespan Li batteries in a cost-effective fashion

A Ga-Sn Liquid Metal Mediated Structural Cathode for Li-O2 Batteries

One of the recent challenges in Li–O2 battery technology is the cycle life, which can be severely shortened by cathode passivation induced by discharge product accumulation; this can be eliminated by reducing the amount of discharge products. Herein, we report a feasibility study on the development of a Ga–Sn liquid metal (LM)-functionalized multiwalled carbon nanotubes (MWNTs) cathode. In a comparison of MWNT, LM, m-LM/MWNT (pre-mixed LM and MWNTs), and LM/MWNT (LM-modified MWNTs) cathodes, morphology analysis showed that small Li2O2 flakes rather than large crystals grow on the conductive Ga–Sn LM and MWNTs of the LM/MWNT cathode only. The decomposition of the flaky Li2O2 on the LM/MWNT cathode occurred at lower charge overpotentials, resulting in low polarization; thus, the cathode passivation and the consumption of the Li anode were both alleviated during the cyclic process. The LM/MWNT cathode significantly improved the cycle life, rate performance, and ultimate capacity of Li–O2 batteries

A Point Mutation in DNA Polymerase β (POLB) Gene Is Associated with Increased Progesterone Receptor (PR) Expression and Intraperitoneal Metastasis in Gastric Cancer

Increased expression of progesterone receptor (PR) has been reported in gastric cancer (GC). We have previously identified a functional T889C point mutation in DNA polymerase beta (POLB), a DNA repair gene in GC. To provide a detailed analysis of molecular changes associated with the mutation, human cDNA microarrays focusing on 18 signal transduction pathways were used to analyze differential gene expression profiles between GC tissues with T889C mutant in POLB gene and those with wild type. Among the differentially expressed genes, notably, PR was one of the significantly up-regulated genes in T889C mutant POLB tissues, which were subsequently confirmed in POLB gene transfected AGS cell line. Interestingly, patients with T889C mutation and PR positivity were associated with higher incidence of intraperitoneal metastasis (IM). In vitro studies indicate that PR expression was upregulated in AGS cell line when transfected with T889C mutant expression vector. Cotransfection of T889C mutant allele and PR gene induced cell migration in the cell line. These data demonstrated that T889C mutation-associated PR overexpression results in increased IM. Therefore, T889C mutation-associated PR overexpression may serve as a biomarker for an adverse prognosis for human GC